Digital pathology implementation in cancer diagnostics: towards informed decision-making.

IF 3.2 Q1 HEALTH CARE SCIENCES & SERVICES
Frontiers in digital health Pub Date : 2024-05-30 eCollection Date: 2024-01-01 DOI:10.3389/fdgth.2024.1358305
Oksana Sulaieva, Oleksandr Dudin, Olena Koshyk, Mariia Panko, Nazarii Kobyliak
{"title":"Digital pathology implementation in cancer diagnostics: towards informed decision-making.","authors":"Oksana Sulaieva, Oleksandr Dudin, Olena Koshyk, Mariia Panko, Nazarii Kobyliak","doi":"10.3389/fdgth.2024.1358305","DOIUrl":null,"url":null,"abstract":"<p><p>Digital pathology (DP) has become a part of the cancer healthcare system, creating additional value for cancer patients. DP implementation in clinical practice provides plenty of benefits but also harbors hidden ethical challenges affecting physician-patient relationships. This paper addresses the ethical obligation to transform the physician-patient relationship for informed and responsible decision-making when using artificial intelligence (AI)-based tools for cancer diagnostics. DP application allows to improve the performance of the Human-AI Team shifting focus from AI challenges towards the Augmented Human Intelligence (AHI) benefits. AHI enhances analytical sensitivity and empowers pathologists to deliver accurate diagnoses and assess predictive biomarkers for further personalized treatment of cancer patients. At the same time, patients' right to know about using AI tools, their accuracy, strengths and limitations, measures for privacy protection, acceptance of privacy concerns and legal protection defines the duty of physicians to provide the relevant information about AHI-based solutions to patients and the community for building transparency, understanding and trust, respecting patients' autonomy and empowering informed decision-making in oncology.</p>","PeriodicalId":73078,"journal":{"name":"Frontiers in digital health","volume":null,"pages":null},"PeriodicalIF":3.2000,"publicationDate":"2024-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11169727/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in digital health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/fdgth.2024.1358305","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Digital pathology (DP) has become a part of the cancer healthcare system, creating additional value for cancer patients. DP implementation in clinical practice provides plenty of benefits but also harbors hidden ethical challenges affecting physician-patient relationships. This paper addresses the ethical obligation to transform the physician-patient relationship for informed and responsible decision-making when using artificial intelligence (AI)-based tools for cancer diagnostics. DP application allows to improve the performance of the Human-AI Team shifting focus from AI challenges towards the Augmented Human Intelligence (AHI) benefits. AHI enhances analytical sensitivity and empowers pathologists to deliver accurate diagnoses and assess predictive biomarkers for further personalized treatment of cancer patients. At the same time, patients' right to know about using AI tools, their accuracy, strengths and limitations, measures for privacy protection, acceptance of privacy concerns and legal protection defines the duty of physicians to provide the relevant information about AHI-based solutions to patients and the community for building transparency, understanding and trust, respecting patients' autonomy and empowering informed decision-making in oncology.

在癌症诊断中实施数字病理:实现知情决策。
数字病理学(DP)已成为癌症医疗系统的一部分,为癌症患者创造了更多价值。在临床实践中实施数字化病理提供了很多好处,但也隐藏着影响医患关系的伦理挑战。本文探讨了在使用基于人工智能(AI)的癌症诊断工具时,为做出知情和负责任的决策而转变医患关系的伦理义务。DP 应用可以提高人类-人工智能团队的绩效,将重点从人工智能的挑战转移到增强人类智能(AHI)的优势上。增强人类智能提高了分析灵敏度,使病理学家能够提供准确诊断,并评估预测性生物标志物,从而进一步对癌症患者进行个性化治疗。与此同时,患者对使用人工智能工具的知情权、其准确性、优势和局限性、隐私保护措施、对隐私问题的接受程度以及法律保护,都规定了医生有责任向患者和社区提供基于人工智能解决方案的相关信息,以建立透明度、理解和信任,尊重患者的自主权,并增强肿瘤学知情决策的能力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
0
审稿时长
13 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信